Roche Assures Investors: “Right Moment Is Now” To Acquire Genentech
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche would consider another Genentech-like deal, but the biotech itself has grown too large and the time is right to bring it in-house, Humer says.